SRPT
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. (SRPT) has 18 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 30, 2026.
Insiders have net sold $123K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Douglas S. Ingram
- Employees:1,372
- HQ:Cambridge, MA, US
- IPO:1997-06-04
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$123K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$1.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Mayo StephenFirst filing | Director | Sale | 7,239 | $123K | Mar 13 | SEC ↗ |
Related companies
Sarepta Therapeutics, Inc. is in the Healthcare sector.